Month: May 2020

 Mean 60 mg HBsAg reduction of 0.99 log10 IU/mL at week 12, with normal ALT and AST values throughout the follow-up period90 mg single-dose and 60 mg multi-dose cohorts initiated with data expected in the second half of 2020Conference Call and Webcast Scheduled Today at 4:30 PM ETWARMINSTER, Pa., May 18, 2020 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company focused on developing a cure for people with chronic hepatitis B virus (HBV) infection, today reports positive follow-up data from a Phase 1a/1b clinical trial (AB-729-001) in chronic HBV subjects on nucleos(t)ide therapy who received a single subcutaneous injection of 60 mg of AB-729, a proprietary GalNAc delivered RNAi compound. William Collier, President and Chief Executive Officer of Arbutus, stated, “These new data...

           Pharmacokinetic comparison of STS101, an intranasal dry powder formulation of dihydroergotamine, with other intranasal, injectable and oral inhaled DHE formulations Water-insoluble Mucoadhesive Formulation Enables Consistent and Rapid Intranasal Absorption of Drugs, including Granisetron, Zolmitriptan and Dihydroergotamine  SOUTH SAN FRANCISCO, Calif., May 18, 2020 (GLOBE NEWSWIRE) — Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA) a clinical-stage biopharmaceutical company, today announced that two abstracts and scientific presentations from its STS101 (dihydroergotamine (DHE) nasal powder) development program for the acute treatment of migraine were selected for presentation on the 2020 American Academy of Neurology (AAN) Annual Meeting Science Highlights Virtual Platform.  The 2020 AAN Science Highlights Virtual Platform...

FREMONT, Calif., May 18, 2020 (GLOBE NEWSWIRE) — Identiv, Inc. (NASDAQ: INVE), a global provider of physical security and secure identification, today announced that the location of its 2020 Annual Meeting of Stockholders (the “Annual Meeting”) has been changed. Due to the ongoing public health impact of the COVID-19 pandemic and in order to prioritize the health and wellbeing of the Company’s stockholders, employees, and other meeting participants, the Company will host its Annual Meeting solely by means of remote communication. The Annual Meeting will be held virtually via a live webcast at virtualshareholdermeeting.com/INVE2020, rather than in person. As previously announced, the Annual Meeting will be held on June 1, 2020 at 8 AM PT (11 AM ET).Stockholders of record as of the close of business on April 3, 2020, or those who...

SAN DIEGO, May 18, 2020 (GLOBE NEWSWIRE) — Leading retail investment advisory firm and independent broker-dealer LPL Financial LLC, a wholly owned subsidiary of LPL Financial Holdings Inc. (Nasdaq: LPLA), today released its monthly activity report for April 2020.Total brokerage and advisory assets served at the end of April were approximately $718.0 billion, an increase of 7.2% compared to the end of March 2020.Total net new assets for April were an inflow of $3.4 billion, translating to a 6.1% annualized growth rate. This includes total net new advisory assets of $2.8 billion, translating to a 10.3% annualized growth rate.Total client cash balances at the end of April were $47.0 billion, a decrease of $0.8 billion compared to the end of March 2020. Net buying in April was $4.1 billion.*Total Net New Assets equals the combination...

EVANSTON, Ill., May 18, 2020 (GLOBE NEWSWIRE) — Fidus Investment Corporation (NASDAQ:FDUS) (“Fidus” or the “Company”) announced today a change in location for its Annual Meeting of Stockholders (the “Annual Meeting”) to be held on Thursday, June 4, 2020 at 9:00 a.m. Central Time. Due to the rapidly evolving public health concerns relating to the coronavirus, or COVID-19, the Company has moved the physical location of the Annual Meeting to the Company’s offices at 1603 Orrington Avenue, Suite 1005, Evanston, IL, 60201. Except for the change of location of the Annual Meeting, all other details of the Annual Meeting, including the proposals to be proposed at the meeting, remain unchanged. As described in the proxy materials for the Annual Meeting previously distributed, stockholders are entitled to participate in and vote at the Annual...

MAROUSSI, ATHENS, Greece, May 18, 2020 (GLOBE NEWSWIRE) — EuroDry Ltd. (NASDAQ: EDRY, the “Company” or “EuroDry”), an owner and operator of drybulk vessels and provider of seaborne transportation for drybulk cargoes, announced today its results for the three-month period ended March 31, 2020.First Quarter 2020 Highlights:Total net revenues of $5.1 million; net loss of $2.3 million; net loss attributable to common shareholders (after a $0.4 million dividend on Series B Preferred Shares) of $2.6 million or $1.17 loss per share basic and diluted. Adjusted net loss attributable to common shareholders1 for the period was $2.1 million or $0.91 per share basic and diluted. Adjusted EBITDA1 was $0.6 million. An average of 7.0 vessels were owned and operated during the first quarter of 2020 earning an average time charter equivalent rate...

SOUDERTON, Pa., May 18, 2020 (GLOBE NEWSWIRE) — Univest Financial Corporation (“Univest”) (NASDAQ: UVSP), parent company of Univest Bank and Trust Co. and its insurance, investments and equipment financing subsidiaries, today declared a $0.20 per share quarterly cash dividend for the second quarter of 2020. The dividend will be paid on July 1, 2020 to shareholders of record as of June 2, 2020.About Univest Financial CorporationUnivest Financial Corporation (UVSP), including its wholly-owned subsidiary Univest Bank and Trust Co., Member FDIC, has approximately $5.5 billion in assets and $3.3 billion in assets under management and supervision through its Wealth Management lines of business at March 31, 2020. Headquartered in Souderton, Pa. and founded in 1876, the Corporation and its subsidiaries provide a full range of...

Shareholders of Infant Bacterial Therapeutics AB (publ) are summoned to the Annual General Meeting on Tuesday, June 16, 2020. In light of the coronavirus, the Annual General Meeting is conducted through advance voting pursuant to temporary regulations. Therefore, it will not be possible to attend this year’s Meeting in person or by proxy.Right to participate In order to participate in the Annual General Meeting (AGM) shareholders must be recorded in the shareholder register maintained by Euroclear Sweden AB no later than Wednesday June 10, 2020. Notification of participation in the Meeting is completed by submitting an advance voting form in accordance with the instructions set forth in the section “Advance voting” below. In order to participate in the AGM, shareholders whose shares are registered in the name of a trustee must register...

Aktieägarna i Infant Bacterial Therapeutics AB (publ) kallas till årsstämma tisdagen den 16 juni 2020. Mot bakgrund av coronaviruset genomförs årsstämman genom förhandsröstning med stöd av tillfälliga lagregler. Någon årsstämma med möjlighet att närvara personligen eller genom ombud kommer därför inte att äga rum det här året.Rätt att delta och anmälan Rätt att delta i stämman har den som är registrerad som aktieägare i den av Euroclear Sweden AB förda aktieboken onsdagen den 10 juni 2020. Anmälan till stämman görs genom att avge en förhandsröst enligt instruktionerna i avsnittet ”Förhandsröstning” nedan. Den som låtit förvaltarregistrera sina aktier måste, för att ha rätt att delta i stämman, genom förvaltares försorg låta registrera aktierna i eget namn. Sådan registrering, som kan vara tillfällig, måste vara verkställd onsdagen den...